clofibrate has been researched along with 1-anilino-8-naphthalenesulfonate in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (85.71) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cenedella, RJ | 1 |
Castillón, MP; Catalán, RE; Priego, JG | 1 |
Arnold, A; Beyler, AL; McAuliff, MP | 1 |
Decoopman, E; Dewailly, P; Fruchart, JC; Jaillard, J; Sezille, G | 1 |
Ehnholm, C; Huttunen, JK; Nikkilä, EA | 1 |
Augustin, J; Greten, H; Laible, V; Zipperle, G | 1 |
Arad, R; Bar-Tana, J; Brandes, R | 1 |
Demacker, PN; Stalenhoef, AF; Stuyt, PM; Van 't Laar, A | 1 |
Basílico, MZ; Chicco, A; de Rodi, MA; Gutman, R; Lombardo, YB; Nusimovich, B | 1 |
Levy, RI | 1 |
Harvengt, C; Heller, F | 1 |
Donike, M; Erking, W; Lücker, PW; Wetzelsberger, K | 1 |
Föger, B; Hopferwieser, T; Lechleitner, M; Menzel, HJ; Patsch, JR; Pfeiffer, KP; Ritsch, A; Tröbinger, G; Utermann, G | 1 |
Agellon, LB; Dolinsky, VW; Gilham, D; Hatch, GM; Lehner, R; Vance, DE | 1 |
1 trial(s) available for clofibrate and 1-anilino-8-naphthalenesulfonate
Article | Year |
---|---|
A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Apolipoproteins B; Cholesterol; Clofibrate; Female; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipase; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Pyrazines; Triglycerides | 1985 |
13 other study(ies) available for clofibrate and 1-anilino-8-naphthalenesulfonate
Article | Year |
---|---|
Hepatic triglyceride lipases--effect of clofibrate and halofenate.
Topics: Animals; Clofibrate; Fatty Acids, Nonesterified; Fatty Liver; Glycolates; Halofenate; Hydrogen-Ion Concentration; In Vitro Techniques; Lipase; Liver; Male; Orotic Acid; Rats; Triglycerides | 1976 |
Effect of clofibrate treatment on the protein kinase and cyclic AMP-binding activities in rat liver.
Topics: Animals; Clofibrate; Cyclic AMP; Depression, Chemical; Lipase; Liver; Male; Protein Kinases; Rats | 1978 |
Metabolic effects of a new hypolipidemic agent, ciprofibrate.
Topics: Animals; Cholesterol; Clofibrate; Clofibric Acid; Fatty Acids, Nonesterified; Fibric Acids; Hypolipidemic Agents; Lipase; Norepinephrine; Polyethylene Glycols; Rats | 1979 |
[Effect of clofibrate on tissue lipase activity in rats].
Topics: Adenylyl Cyclase Inhibitors; Adipose Tissue; Animals; Clofibrate; Diet; Enzyme Activation; Fasting; Heart; Lipase; Lipid Mobilization; Lipoprotein Lipase; Male; Myocardium; Rats; Triglycerides | 1976 |
Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia.
Topics: Adult; Cholesterol; Clofibrate; Fatty Acids, Nonesterified; Female; Heparin; Humans; Lipase; Lipoprotein Lipase; Male; Middle Aged; Triglycerides | 1977 |
Comparison of assay methods for selective measurement of plasma lipase. The effect of clofibrate on hepatic and lipoprotein lipase in normals and patients with hypertriglyceridemia.
Topics: Adolescent; Adult; Aged; Clofibrate; Humans; Hyperlipidemias; Lipase; Lipoprotein Lipase; Liver; Methods; Middle Aged | 1977 |
Adipose conversion of cultured rat primary preadipocytes by hypolipidemic drugs.
Topics: Adipose Tissue; Animals; Bezafibrate; Bucladesine; Cell Differentiation; Cells, Cultured; Clofibrate; Cyclic AMP; Glycerolphosphate Dehydrogenase; Hypolipidemic Agents; Lipase; Lipoprotein Lipase; Male; Rats; Triglycerides | 1986 |
Effects of tiadenol and clofibrate on plasma post heparin lipolytic hepatic, extrahepatic and monoglyceride hydrolase activities in rats with hypertriglyceridemia induced by a sucrose rich diet.
Topics: Animals; Clofibrate; Fatty Alcohols; Heparin; Hyperlipidemias; Lipase; Lipolysis; Lipoprotein Lipase; Liver; Male; Monoacylglycerol Lipases; Rats; Rats, Inbred Strains; Triglycerides | 1985 |
Hyperlipoproteinemia. Some basic concepts on diagnosis and management.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Blood Protein Disorders; Body Weight; Cholesterol; Chylomicrons; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Lipase; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Neomycin; Nicotinic Acids; Sodium; Triglycerides | 1973 |
Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.
Topics: Adult; Bezafibrate; Cholesterol; Clofibrate; Fenofibrate; Humans; Hypolipidemic Agents; Lipase; Lipolysis; Lipoprotein Lipase; Male; Phosphatidylcholine-Sterol O-Acyltransferase; Probucol; Triglycerides | 1983 |
[Metabolism and pharmacokinetics of etofylline clofibrate, new antilipemic].
Topics: Animals; Clofibrate; Dogs; Hypolipidemic Agents; Intestinal Absorption; Intestinal Mucosa; Kinetics; Lipase; Rats; Species Specificity | 1980 |
Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.
Topics: Carrier Proteins; Cholesterol Ester Transfer Proteins; Chylomicrons; Clofibrate; Eating; Female; Glycoproteins; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Transaminases; Triglycerides; Vitamin A | 1995 |
Regulation of triacylglycerol hydrolase expression by dietary fatty acids and peroxisomal proliferator-activated receptors.
Topics: 3T3 Cells; Adipocytes; Animals; Clofibrate; Dietary Fats; Female; Gene Expression Regulation, Enzymologic; Lipase; Mice; Mice, Inbred C57BL; Microsomes, Liver; Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors | 2003 |